Estrogen therapy fails to alter amyloid deposition in the PDAPP model of Alzheimer's disease

Endocrinology

Volumn 146, Issue 6, 2005, Pages 2774-2781

  Green, Pattie S ^a,b,d   Bales, Kelly ^c   Paul, Steven ^c   Bu, Guojun ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; ESTRADIOL; ESTROGEN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; GENE MUTATION; HIPPOCAMPUS; IMMUNOREACTIVITY; MOUSE; NEOCORTEX; NONHUMAN; ORGAN WEIGHT; OVARIECTOMY; PITUITARY GLAND WEIGHT; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN SECRETION; TREATMENT FAILURE; UTERUS WEIGHT; VAGINA CYTOLOGY;

EID: 18844450475     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-1433     Document Type: Article

References (46)

1. Alzheimer's Association 2002 Statistics: about Alzheimer's disease. http://www.alz.org/Resources/FactSheets/FSAlzheimerStats.pdf, visited 08/12/03
2. Brookmeyer R, Gray S, Kawas C 1998 Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 88:1337-1342
3. Fillit H, Weinreb H, Cholst I, Luine V, McEwen B, Amador R, Zabriskie J 1986 Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type. Psychoneuroendocrinology 11:337-345
4. Paganini-Hill A, Henderson VW 1996 Estrogen replacement therapy and risk of Alzheimer disease. Arch Intern Med 156:2213-2217
5. Waring SC, Rocca WA, Petersen RC, O'Brien PC, Tangalos EG, Kokmen E 1999 Postmenopausal estrogen replacement therapy and risk of AD: a population-based study. Neurology 52:965-970
6. Mortel KF, Meyer JS 1995 Lack of postmenopausal estrogen replacement therapy and the risk of dementia. J Neuropsychiatry Clin Neurosci 7:334-337
7. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R 1996 Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348:429-432
8. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, Bacal C, Lingle DD, Metter E 1997 A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 48:1517-1521
9. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, Breitner JC; Cache County Memory Study Investigators 2002 Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 288:2123-2129
10. Brenner DE, Kukull WA, Stergachis A, van Belle G, Bowen JD, McCormick WC, Ten L, Larson EB 1994 Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am J Epidemiol 140:262-267
11. Henderson VW, Paganini-Hill A, Miller BL, Elble RJ, Reyes PF, Shoupe D, McCleary CA, Klein RA, Hake AM, Farlow MR 2000 Estrogen for Alzheimer disease in women: randomized, double-blind, placebo-controlled trial. Neurology 54:295-301
12. Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, Koss E, Pfeiffer E, Jin S, Gamst A, Grundman M, Thomas R, Thai LJ 2000 Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease. JAMA 283:1007-1015
13. Wang PN, Liao SQ, Liu RS, Liu CY, Chao HT, Lu SR, Yu HY, Wang SJ, Liu HC 2000 Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study. Neurology 54:2061-2066
14. Hardy J, Selkoe DJ 2002 The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353-356
15. Jaffe AB, Toran-Allerand CD, Greengard P, Gandy SE 1994 Estrogen regulates metabolism of Alzheimer amyloid β precursor protein. J Biol Chem 269:13065-13068
16. Xu H, Gouras GK, Greenfield JP, Vincent B, Naslund J, Mazzarelli L, Fried G, Jovanovic JN, Seeger M, Relkin NR, Liao F, Checler F, Buxbaum JD, Chait BT, Thinakaran G, Sisodia SS, Wang R, Greengard P, Gandy S 1998 Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides. Nat Med 4:447-451
17. Greenfield JP, Leung LW, Cai D, Kaasik K, Gross RS, Rodriguez-Boulan E, Greengard P, Xu H 2002 Estrogen lowers Alzheimer β-amyloid generation by stimulating trans-Golgi network vesicle biogenesis. J Biol Chem 277:12128-12136
18. Manthey D, Heck S, Engert S, Behl C 2001 Estrogen induces a rapid secretion of amyloid β precursor protein via the mitogen-activated protein kinase pathway. Eur J Biochem 268:4285-4291
19. Petanceska SS, Nagy V, Frail D, Gandy S 2000 Ovariectomy and 17β-estradiol modulate the levels of Alzheimer's amyloid β peptides in brain. Exp Gerontol 35:1317-1325
20. Zheng H, Xu H, Uljon SN, Gross R, Hardy K, Gaynor J, Lafrancois J, Simpkins J, Refolo LM, Petanceska S, Wang R, Duff K 2002 Modulation of A(β) peptides by estrogen in mouse models. J Neurochem 80:191-196
21. Murrell J, Farlow M, Ghetti B, Benson MD 1991 A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254:97-99
22. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G 1996 Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274:99-102
23. Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, Prada CM, Kim G, Seekins S, Yager D, Slunt HH, Wang R, Seeger M, Levey AI, Gandy SE, Copeland NG, Jenkins NA, Price DL, Younkin SG, Sisodia SS Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron 17:1005-1013
24. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J 1995 Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373:523-527
25. Johnson-Wood K, Lee M, Motter R, Hu K, Gordon G, Barbour R, Khan K, Gordon M, Tan H, Games D, Lieberburg I, Schenk D, Seubert P, McConlogue L 1997 Amyloid precursor protein processing and A β42 deposition in a transgenic mouse model of Alzheimer disease. Proc Natl Acad Sci USA 94:1550-1555
26. Nelson JF, Felicio LS, Randall PK, Sims C, Finch CE 1982 A longitudinal study of estrous cyclicity in aging C57BL/6J mice: I. Cycle frequency, length and vaginal cytology. Biol Reprod 27:327-339
27. Champlin AK 1971 Suppression of oestrus in grouped mice: the effects of various densities and the possible nature of the stimulus. J Reprod Fertil 27:233-241
28. Gandy S, Duff K 2000 Post-menopausal estrogen deprivation and Alzheimer's disease. Exp Gerontol 35:503-511
29. Levin-Allerhand JA, Lominska CE, Wang J, Smith JD 2002 17α-Estradiol and 17β-estradiol treatments are effective in lowering cerebral amyloid-β levels in AβPPSWE transgenic mice. J Alzheimers Dis 4:449-457
30. Callahan MJ, Lipinski WJ, Bian F, Durham RA, Pack A, Walker LC 2001 Augmented senile plaque load in aged female Aβprecursor protein-transgenic mice. Am J Pathol 158:1173-1177
31. Suzuki N, Cheung TT, Cai XD, Odaka A, Otvos Jr L, Eckman C, Golde TE, Younkin SG 1994 An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (β APP717) mutants. Science 264:1336-1340
32. Lamb BT Call LM, Slunt HH, Bardel KA, Lawler AM, Eckman CB, Younkin SG, Holtz G, Wagner SL, Price DL, Sisodia SS, Gearhart JD 1997 Altered metabolism of familial Alzheimer's disease-linked amyloid precursor protein variants in yeast artificial chromosome transgenic mice. Hum Mol Genet 6:1535-1541
33. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ 1992 Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360:672-674
34. Gibbs RB 2000 Effects of gonadal hormone replacement on measures of basal forebrain cholinergic function. Neuroscience 101:931-938
35. Asthana S, Baker LD, Craft S, Stanczyk FZ, Veith RC, Raskind MA, Plymate SR 2001 High-dose estradiol improves cognition for women with AD: results of a randomized study. Neurology 57:605-612
36. Asthana S, Craft S, Baker LD, Raskind MA, Birnbaum RS, Lofgreen CP, Veith RC, Plymate SR 1999 Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study. Psychoneuroendocrinology 24:657-677
37. Goodman Y, Bruce AJ, Cheng B, Mattson MP 1995 Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons. J Neurochem 66:1836-1844
38. Green PS, Bishop J, Simpkins JW 1997 17α-Estradiol exerts neuroprotective effects on SK-N-SH cells. J Neurosci 17:511-515
39. Green PS, Yang SH, Nilsson KR, Kumar AS, Covey DF, Simpkins JW 2001 The nonfeminizing enantiomer of 17β-estradiol exerts protective effects in neuronal cultures and a rat model of cerebral ischemia. Endocrinology 142:400-406
40. Wise PM, Dubal DB 2000 Estradiol protects against ischemic brain injury in middle-aged rats. Biol Reprod 63:982-985
41. Singh M, Setalo Jr G, Guan X, Warren M, Toran-Allerand CD 1999 Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J Neurosci 19:1179-1188
42. Brinton RD 1993 17β-Estradiol induction of filopodial growth in cultured hippocampal neurons within minutes of exposure. Mol Cell Neurosci 4:36-46
43. Woolley CS, McEwen BS 1994 Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. J Neurosci 14:7680-7687
44. Murphy DD, Segal M 1996 Regulation of dendritic spine density in cultured rat hippocampal neurons by steroid hormones. J Neurosci 16:4059-4068
45. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH, WHIMS Investigators 2004 Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 23:2947-2958
46. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones 3rd BN, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J; WHIMS Investigators 2003 Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2651-2662